Polycystic ovary syndrome is one of the most common endocrine disorders in people of reproductive age and one of the most poorly explained. The name is misleading, plenty of people with PCOS do not have cysts on their ovaries, and plenty with ovarian follicles visible on ultrasound do not have PCOS. What ties the diagnosis together is a pattern: irregular ovulation, signs of elevated androgens, and often, though not always, metabolic changes that ripple outward from the reproductive system.
Estimates from ACOG and the Endocrine Society place prevalence somewhere between 6 and 12 percent of people with ovaries, though a substantial share remain undiagnosed or misdiagnosed for years.
What PCOS actually is
PCOS is a syndrome, meaning a cluster of features rather than a single mechanism. The most widely used framework, the Rotterdam criteria, requires two of the following three:
- Irregular or absent ovulation, which usually shows up as unpredictable or missing periods
- Clinical or biochemical signs of high androgens, such as acne, unwanted hair growth, or elevated blood testosterone
- Polycystic ovarian morphology on ultrasound, meaning many small follicles arrested in early development
Other conditions with overlapping symptoms, thyroid disorders, hyperprolactinemia, congenital adrenal hyperplasia, need to be ruled out first. That is why PCOS is sometimes called a diagnosis of exclusion.
Insulin resistance is not part of the diagnostic criteria but is present in a majority of people with PCOS, including those at a normal weight. It appears to be one of the drivers pushing the ovaries to overproduce androgens.
Why it often takes years to diagnose
Periods can be dismissed as irregular for other reasons. Acne and hair growth can be treated symptomatically without ever tracing the cause. Many people are told to lose weight without further workup, even though weight loss alone does not resolve the syndrome and PCOS occurs across body sizes.
A meaningful share of people with PCOS report seeing three or more clinicians before receiving a diagnosis, and some wait more than five years.
The consequences of delayed diagnosis are real. Untreated PCOS is associated with higher rates of type 2 diabetes, endometrial cancer (from long stretches of unopposed estrogen), cardiovascular disease, and depression.
What actually helps
There is no cure, but the syndrome responds well to targeted management. Treatment depends on which symptoms are most bothersome and whether pregnancy is a current goal.
For cycle regulation and androgen symptoms, combined hormonal contraceptives are first-line for many people. They lower androgen levels, protect the uterine lining, and make periods predictable. Anti-androgens like spironolactone are often added for persistent acne or hirsutism.
For insulin resistance and metabolic risk, metformin has decades of use in PCOS, particularly for people with impaired glucose tolerance. Newer evidence supports GLP-1 receptor agonists for weight and metabolic effects in appropriate candidates, though long-term reproductive-health data is still developing.
For fertility, letrozole is now the preferred first-line ovulation induction agent, having largely displaced clomiphene based on trials showing higher live-birth rates in PCOS.
For lifestyle, sustained modest changes matter more than dramatic ones. A dietary pattern that stabilizes blood glucose, regular resistance and aerobic training, and sleep sufficient to support insulin sensitivity all move the needle. Weight loss, when appropriate, can restore ovulation in a meaningful share of people, but it is not a moral prescription and is not the only lever.
What to ask your clinician
If you suspect PCOS, useful requests include a full androgen panel (total and free testosterone, DHEA-S), a fasting insulin and glucose or HbA1c, thyroid and prolactin, and a pelvic ultrasound. Ask whether the Rotterdam criteria are being applied and which of your findings meet which criterion. Ask what your baseline metabolic risk is, independent of weight.
The bottom line
PCOS is common, heterogeneous, and treatable, but rarely with a single intervention. It sits at the intersection of endocrine, metabolic, and reproductive health, which is precisely why it is missed. Getting a clear diagnosis and a plan matched to your specific pattern, rather than a blanket recommendation, is what changes the trajectory.